Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (NYSE: MCK) is a diversified healthcare services and pharmaceutical distribution company that regularly issues news and updates relevant to investors, healthcare partners, and other stakeholders. The company describes itself as dedicated to advancing health outcomes for patients everywhere, partnering with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services that support access to quality care.
The McKesson news feed typically features announcements about quarterly and annual financial results, earnings release dates, and related investor webcasts. These updates often include information about fiscal guidance, long-term financial targets, and commentary on strategic priorities and business outlook shared during events such as Investor Day.
In addition to earnings and guidance, McKesson’s news includes Board actions such as dividend declarations, reflecting decisions on returning capital to shareholders. The company also issues releases on organizational and segment reporting changes, including the introduction of its North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions segments, along with portfolio developments like planned separations or divestitures.
McKesson may also appear in third-party announcements highlighting distribution agreements and collaborations that illustrate its role in pharmaceutical distribution and healthcare services. Such items can show how McKesson supports access to therapies through its distribution networks and healthcare supply chain capabilities.
For readers tracking MCK news, this page provides a centralized view of financial announcements, strategic updates, capital allocation decisions, and partnership-related developments. Regularly reviewing these items can help investors and observers understand how McKesson communicates its performance, segment evolution, and strategic focus within the healthcare and wholesale trade landscape.
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on July 3, 2023, to stockholders recorded as of June 1, 2023. McKesson, a leader in healthcare services, focuses on improving health outcomes by partnering with various sectors including biopharma companies, care providers, and pharmacies. The company aims to enhance accessibility and affordability in healthcare, impacting numerous areas within the industry.
McKesson Corporation (NYSE: MCK) is set to release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. A live webcast of the earnings conference call will be held at 4:30 PM Eastern Time to discuss the financial outcomes. Investors can access the webcast on McKesson’s Investor Relations website, where the earnings release and supporting materials will also be available. McKesson is a leader in healthcare services, dedicated to improving health outcomes and partnering with various stakeholders to enhance the accessibility and affordability of quality care.
McKesson Medical-Surgical Government Solutions LLC, based in Richmond, Va., has been awarded a five-year contract by the U.S. Department of Veterans Affairs for Federal Supply Schedule 65 II A. This contract allows greater access to McKesson’s medical supplies, including respiratory accessories and surgical instruments. According to Deborah Haywood, VP of Government Solutions, this milestone enhances McKesson’s ability to positively impact patient outcomes and create cost efficiencies in healthcare. The inclusion on the FSS facilitates expansion in providing high-quality medical supplies to federal customers, especially for veterans and the military community.
McKesson Corporation (NYSE: MCK) has announced its financial results for the third quarter of fiscal 2023. The detailed results are accessible on McKesson's Investor Relations website. A live webcast to discuss these results is scheduled for February 1st at 4:30 PM ET. McKesson is recognized as a leader in healthcare services, focusing on enhancing health outcomes through partnerships with various stakeholders, including biopharma companies and care providers. For additional insights about the company's impact in healthcare, visit McKesson.com.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on April 3, 2023, to stockholders of record as of March 1, 2023. McKesson is a leader in diversified healthcare services, committed to enhancing health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) will announce its third-quarter fiscal 2023 financial results on February 1, 2023, after market close. Investors can join a live webcast at 4:30 PM Eastern Time to discuss the results. The webcast will be accessible through McKesson's Investor Relations website, where the earnings release and financial documents will also be available. McKesson is a leader in healthcare services, partnering with various stakeholders to enhance healthcare access and affordability.
McKesson Corporation (NYSE: MCK) has announced its fiscal 2023 second-quarter financial results, which are available on their Investor Relations website. A live webcast for investors will be held on November 1 at 4:30 PM ET to discuss these results. McKesson, a leader in healthcare services, is committed to enhancing health outcomes for patients by collaborating with various healthcare stakeholders. For more information on McKesson's financials and upcoming events, please visit their Investor Relations site.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share. This dividend is set to be paid on January 3, 2023, to stockholders of record as of December 1, 2022. McKesson, a leader in healthcare services, aims to improve health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) announced an extension of its partnership with CVS Health to distribute pharmaceuticals through June 2027. This partnership, which has lasted over 20 years, aims to improve health outcomes for patients. Additionally, McKesson will release its second-quarter fiscal 2023 earnings results on November 1, 2022, with a conference call scheduled at 4:30 PM Eastern Time. The live webcast will be accessible through McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has announced the acquisition of Rx Savings Solutions for up to
FAQ
What is the current stock price of McKesson (MCK)?
What is the market cap of McKesson (MCK)?
